CJC 1295 with DAC CD5 5mg*10vials

CJC 1295 DAC CD5 5mg x 10 Vials

Product Overview

CJC 1295 DAC CD5 is an upgraded intermediate- to long-acting growth hormone-releasing hormone analog research peptide, serving as a mid-range upgrade from the basic CD2 version in the CD series. CD5 retains the classic DAC drug affinity complex albumin-binding modification technology, supporting stable 6-8 day ultra-long circulating half-life research, DPP-IV enzyme degradation and rapid renal clearance effective resistance studies. CD5 has optimized molecular activity and is available in a standard 5mg concentration, supporting GH and IGF-1 axis activation efficiency significant enhancement research compared to CD2, combining stable long-acting properties with significant experimental phenotypic differentiation capability research. It is suitable for medium-dose gradient efficacy studies, moderate-intensity body composition remodeling research, anti-aging endocrine mechanism validation research, and long-term highly stable metabolic intervention experiments. As a core upgraded ingredient in mainstream long-acting growth hormone peptide series, CJC 1295 DAC CD5 covers most routine and advanced preclinical endocrine research scenarios.

Core Research Functions

Pituitary Growth Hormone Synthesis and Secretion Stable Potent Stimulation: Supports pituitary growth hormone synthesis and secretion stable potent stimulation research, sustained high-amplitude systemic IGF-1 level upregulation achievement studies.

Long-Acting DAC Modification Technology and Sustained Physiological Endocrine Stimulation: Supports unique long-acting DAC modification technology research, sustained physiological endocrine stimulation for several days provision studies, and short-acting peptide hormone levels drastic fluctuations related avoidance research.

Anabolic and Lipolytic Activity Enhancement and Intuitive Significant Experimental Results: Supports stronger anabolic and lipolytic activity research compared to mild low-dose CD2 version, producing more intuitive significant experimental results research.

Lean Muscle Tissue Proliferation and Repair and Systemic Fat Metabolism Regulation: Supports lean muscle tissue proliferation and repair moderate promotion research, systemic fat metabolism effective regulation studies, collagen synthesis and skin connective tissue remodeling deep promotion research, and age-related endocrine atrophy and metabolic decline mid-term intervention studies.

Balanced Efficacy and Model Tolerability and Medium-to-High Threshold GH and IGF-1 Axis Mechanism Studies: Supports balanced efficacy and model tolerability research, low-dose phenotypic ambiguity and high-dose physiological stress related avoidance studies, providing high-quality high-discrimination reproducible core data for medium-to-high threshold GH and IGF-1 axis mechanism studies.

Compared to the mild low-dose CD2 version, CD5 supports stronger anabolic and lipolytic activity research, producing more intuitive significant experimental results. CD5 demonstrates balanced efficacy and model tolerability, supporting low-dose phenotypic ambiguity and high-dose physiological stress related avoidance studies, providing high-quality high-discrimination reproducible core data for medium-to-high threshold GH and IGF-1 axis mechanism studies.

Core Product Advantages

CD5 Intermediate Enhancement Iteration: An intermediate-level upgrade based on CD2, optimizing molecular activity and target binding efficiency. While maintaining stable long-acting properties, it supports endocrine activation intensity significant enhancement research, bridging the research gap between basic low-dose and extremely high-dose studies.

Stable DAC Long-Acting Core Mechanism: Mature albumin-binding modification technology supports strong anti-enzymatic degradation ability research, maintaining 6-8 day ultra-long half-life studies. It supports low-frequency dosing and long-term continuous intervention research, improving chronic endocrine modeling efficiency research.

5mg Standard Balanced Concentration: The classic mainstream intermediate-potency specification in the CD series. It supports low-dose CD2 product insufficient efficacy related problem research, taking into account experimental safety and phenotypic significance, suitable for most routine gradient experiments and batch replication validation.

High-Purity Selective Endocrine Regulation: Supports GHRH-GH-IGF-1 signaling axis precise targeting with high specificity research. It supports anabolic metabolism and metabolism effective regulation research, cortisol and prolactin stress hormone interference related studies, ensuring experimental variable purity and reliability research.

Pharmaceutical-Grade Process and Standard Packaging: Utilizing aseptic vacuum freeze-drying technology for enhanced activity locking research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). Each box contains 10 vials in integrated aseptic packaging, meeting the needs of routine laboratory research, university key endocrinology projects, and large-scale wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 5mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).